Brief: Adial Pharmaceuticals Awarded Additional U.S. Patent
June 14 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS AWARDED ADDITIONAL U.S. PATENT
COMBINING
THE USE OF THE COMPANY’S PROPRIETARY GENETIC DIAGNOSTIC WITH
AD04 TO TREAT ALCOHOL AND DRUG DEPENDENCE
Source text for Eikon: ID:nGNX3RD47r
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)